Mu DB - Search Results

1

Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases.

Dou X, Wang RB, Yan HJ, Jiang SM, Meng XJ, Zhu KL, Xu XQ, Mu DB. Dou X, et al. Among authors: mu db. Asian Pac J Cancer Prev. 2013;14(6):3881-5. doi: 10.7314/apjcp.2013.14.6.3881. Asian Pac J Cancer Prev. 2013. PMID: 23886201 Free article.

2

[Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma].

Jiang SM, Wang RB, Yu JM, Zhu KL, Mu DB, Xu ZF. Jiang SM, et al. Among authors: mu db. Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):602-5. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19102938 Chinese.

3

Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapy.

Yan H, Yu J, Wang R, Jiang S, Zhu K, Mu D, Xu Z. Yan H, et al. Med Oncol. 2012 Mar;29(1):168-73. doi: 10.1007/s12032-011-9819-x. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264534

4

Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma.

Yan H, Wang R, Zhu K, Zhao W, Jiang S, Feng R, Xu X, Meng X, Sun H, Zhang H, Mu D, Xu Z. Yan H, et al. Tumori. 2011 Nov-Dec;97(6):717-23. doi: 10.1177/030089161109700607. Tumori. 2011. PMID: 22322837

5

Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy.

Yan H, Wang R, Yu J, Jiang S, Zhu K, Mu D, Xu Z. Yan H, et al. Oncol Lett. 2010 Jul;1(4):641-647. doi: 10.3892/ol_00000113. Epub 2010 Jul 1. Oncol Lett. 2010. PMID: 22966357 Free PMC article.

6

PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.

Dou X, Wang RB, Meng XJ, Yan HJ, Jiang SM, Zhu KL, Xu XQ, Chen D, Song XR, Mu DB. Dou X, et al. Among authors: mu db. Asian Pac J Cancer Prev. 2014;15(2):825-30. doi: 10.7314/apjcp.2014.15.2.825. Asian Pac J Cancer Prev. 2014. PMID: 24568503 Free article.

7

The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.

Dou X, Wang R, Meng X, Yan H, Jiang S, Zhu K, Xu X, Chen D, Song X, Mu D. Dou X, et al. Cancer Biomark. 2015;15(2):181-8. doi: 10.3233/CBM-140452. Cancer Biomark. 2015. PMID: 25519018

8

Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.

Teng F, Meng X, Kong L, Mu D, Zhu H, Liu S, Zhang J, Yu J. Teng F, et al. Transl Res. 2015 Dec;166(6):721-732.e1. doi: 10.1016/j.trsl.2015.06.019. Epub 2015 Jul 6. Transl Res. 2015. PMID: 26209749

9

Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.

Teng F, Mu D, Meng X, Kong L, Zhu H, Liu S, Zhang J, Yu J. Teng F, et al. Am J Cancer Res. 2015 May 15;5(6):2064-74. eCollection 2015. Am J Cancer Res. 2015. PMID: 26269765 Free PMC article.

10

Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer.

Meng X, Huang Z, Di J, Mu D, Wang Y, Zhao X, Zhao H, Zhu W, Li X, Kong L, Xing L. Meng X, et al. Medicine (Baltimore). 2015 Nov;94(47):e2106. doi: 10.1097/MD.0000000000002106. Medicine (Baltimore). 2015. PMID: 26632727 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters